Prostate Cancer - Results from #21400

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time - Abstract January 28, 2014

Metabolic syndrome in patients with prostate cancer undergoing androgen suppression - Abstract January 28, 2014

Impact of psychological distress on prostate cancer screening in U.S. military veterans - Abstract January 28, 2014

Single skull metastasis 15 years after primary treatment of prostate cancer and with undetectable PSA levels: a case report and review of the literature - Abstract January 28, 2014

Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy - Abstract January 28, 2014

Focus: Prostate cancer and PET-choline - Abstract January 27, 2014

Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy - Abstract January 27, 2014

Should all colorectal cancer patients over age 60 be screened for prostate cancer? - Abstract January 27, 2014

Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer - Abstract January 27, 2014

ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer - Abstract January 27, 2014

18F-Choline PET/CT pitfalls in image interpretation: An update on 300 examined patients with prostate cancer - Abstract January 27, 2014

Radical prostatectomy for clinically localised prostate cancer at Rigshospitalet 1995-2011 - Abstract January 25, 2014

A cohort study investigating aspirin use and survival in men with prostate cancer - Abstract January 25, 2014

Efficacy of tegafur-uracil (UFT) administration in castration-resistant prostate cancer patients with a history of both alternative antiandrogen therapy and estramustine phosphate sodium hydrate therapy - Abstract January 25, 2014

31 P MR spectroscopic imaging combined with 1 H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T - Abstract January 25, 2014

MRI target delineation may reduce long-term toxicity after prostate radiotherapy - Abstract January 25, 2014

Psychotherapy: A missing piece in the puzzle of post radical prostatectomy erectile dysfunction rehabilitation - Abstract January 25, 2014

The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer-A benchmark for high-tech external beam radiotherapy alone? - Abstract January 25, 2014

Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: Is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring? - Abstract January 25, 2014

Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsy - Abstract January 25, 2014

Page 1071 of 1437